US BROKER MOVES: LOW upgraded at Citi; GTM sees multiple downgrades
SourceNewsquawk
SectionUS Equities
UPGRADES
- Autodesk (ADSK) Upgraded to Buy at BofA; PT USD 300
- Bentley Systems (BSY) Upgraded to Buy at BofA; PT USD 40
- Celanese (CE) Upgraded to Overweight at JPMorgan; PT USD 68
- Lowe's (LOW) Upgraded to Buy at Citi; PT USD 285
- Matador Resources (MTDR) Upgraded to Buy at Truist Secs; PT USD 67
- Seadrill (SDRL) Upgraded to Buy at Fearnley; PT USD 58
DOWNGRADES
- Accuray (ARAY) Downgraded to Hold at Jefferies; PT 35 cents
- Emerald Holding (EEX) Downgraded to Neutral at Rosenblatt Securities Inc
- Gitlab (GTLB) Downgraded to Market Perform at Raymond James
- LENZ Therapeutics Inc (LENZ) Downgraded to Neutral at Piper Sandler; PT USD 12
- Toast (TOST) Downgraded to Neutral at Rothschild & Co Redburn; PT USD 35
- United Parks & Resorts (PRKS) Downgraded to Hold at Stifel; PT USD 40
- ZoomInfo (GTM) Downgraded to Hold at Canaccord; PT USD 5
- ZoomInfo (GTM) Downgraded to Underweight at Piper Sandler; PT USD 4
- ZoomInfo (GTM) Downgraded to Hold at Stifel; PT USD 4
INITIATIONS
- Aevex (AVEX) Initiated at New Outperform at William Blair
- Aevex (AVEX) Initiated at New Outperform at Raymond James; PT USD 35
- Aevex (AVEX) Initiated at New Buy at Jefferies; PT USD 32
- Aevex (AVEX) Initiated at New Outperform at Baird; PT USD 38
- Aevex (AVEX) Initiated at New Outperform at RBC; PT USD 31
- Aevex (AVEX) Initiated at New Overweight at JPMorgan; PT USD 33
- Aevex (AVEX) Initiated at New Buy at Goldman; PT USD 34
- Alamar Biosciences (ALMR) Initiated at New Outperform at Leerink; PT USD 35
- Alamar Biosciences (ALMR) Initiated at New Buy at TD Cowen; PT USD 30
- Alamar Biosciences (ALMR) Initiated at New Overweight at JPMorgan; PT USD 30
- Alamar Biosciences (ALMR) Initiated at New Buy at Stifel; PT USD 28
- Annexon (ANNX) Initiated at New Neutral at Goldman; PT USD 7
- Chesapeake Utilities (CPK) Reinstated Equal-Weight at Wells Fargo
- Design Therapeutics (DSGN) Initiated at New Overweight at Cantor
- Dexcom (DXCM) Initiated at New Buy at Benchmark
- Enliven Therapeutics (ELVN) Initiated at New Buy at Guggenheim; PT USD 80
- Forum Markets (FRMM) Initiated at New Buy at Clear Street; PT USD 11
- H2O America (HTO) Reinstated Equal-Weight at Wells Fargo; PT USD 60
- Insulet (PODD) Initiated at New Buy at Benchmark
- Kailera Therapeutics (KLRA) Initiated at New Outperform at Evercore ISI
- Kailera Therapeutics (KLRA) Initiated at New Outperform at Leerink; PT USD 36
- Kailera Therapeutics (KLRA) Initiated at New Buy at TD Cowen; PT USD 57
- Kailera Therapeutics (KLRA) Initiated at New Outperform at William Blair
- Kailera Therapeutics (KLRA) Initiated at New Buy at Jefferies; PT USD 48
- Kailera Therapeutics (KLRA) Initiated at New Overweight at JPMorgan; PT USD 30
- Lumentum (LITE) Initiated at New Buy at CTBC Securities; PT USD 1,250
- MaxLinear (MXL) Reinstated Buy at Benchmark; PT USD 28
- MiniMed Group (MMED) Initiated at New Buy at Benchmark
- New Jersey Resources (NJR) Reinstated Overweight at Wells Fargo
- Northwest Natural (NWN) Reinstated Underweight at Wells Fargo; PT USD 50
- ONE Gas (OGS) Reinstated Underweight at Wells Fargo; PT USD 85
- Palvella Therapeutics (PVLA) Initiated at New Overweight at Stephens; PT USD 220
- Southwest Gas (SWX) Reinstated Overweight at Wells Fargo; PT USD 105
- Spire (SR) Reinstated Overweight at Wells Fargo; PT USD 96
- Sunbelt Rentals (SUNB) Initiated at New Outperform at Bernstein; PT USD 86
- Tandem Diabetes (TNDM) Initiated at New Hold at Benchmark
- UGI (UGI) Reinstated Overweight at Wells Fargo; PT USD 46
- Unitil (UTL) Initiated at New Equal-Weight at Wells Fargo; PT USD 56
- Varonis Systems (VRNS) Initiated at New Buy at Rosenblatt Securities Inc
- Versant Media (VSNT) Initiated at New Neutral at JPMorgan; PT USD 43